2C-T-27
2C-T-27, also known as 4-benzylthio-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
2C-T-27, also known as 4-benzylthio-2,5-dimethoxyphenethylamine, is a psychedelic drug of the phenethylamine and 2C families.
Use and effects
2C-T-27 has been reported to produce hallucinogenic effects in humans. Its dose was reported by Daniel Trachsel to be 80 mg or more orally and no duration was listed.
Pharmacodynamics
In addition to the serotonin 5-HT 2A receptor, 2C-T-27 interacts with the serotonin 5-HT 2C receptor. It showed higher affinity for the serotonin 5-HT 2A receptor than any other 2C drug (K i = 1.6 nM), but its activational potency and efficacy were among the lowest ( = 26 nM; = 27%). The drug produces the head-twitch response (HTR), a behavioral proxy of psychedelic effects, in rodents. However, the HTR induced by 2C-T-27 is relatively weak.
Analogues
Analogues of 2C-T-27 include 2C-T-6, 2C-T-31, and 2C-T-33, among others.
History
2C-T-27 was first synthesized and described by Daniel Trachsel in 2003.
Canada
2C-T-27 is a controlled substance in Canada under phenethylamine blanket-ban language.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1371212398 under CC BY-SA 4.0; modifications have been made.